A specially sharpened device for early cancer diagnosis and treatment effect inspection

Abstract

The invention discloses a device which has a special pre-sharpening processing unit and can automatically perform early diagnosis and treatment effect inspection on cancer. The device integrates a specific fluorescence spectrometer, polarizing devices with different characteristics, a refrigerated centrifuge, a specific diluter and a computer with various software, etc. It can detect the fluorescence spectrum and characteristic spectrum of the patient's blood and their changing characteristics. Including the 515nm main peak of the fluorescence spectrum and the 624nm characteristic peak intensity ratio, the normalized half-peak width of the main peak, the parallel-perpendicular, vertical-parallel, parallel-parallel and vertical-vertical normalized intensity values ​​of the polarized fluorescence spectrum, the degree of polarization of serum, anisotropy Indexes such as heterosexual value and viscosity are used to realize early diagnosis of cancer and check the effect of treatment. The feature of this device is that the above-mentioned five major devices are integrated into one instrument, which can make early diagnosis of various cancers. The diagnosis principle is clear, the operation is convenient, the precision is high, the speed is fast and the cost is low, and the in vitro detection is non-invasive.

Description

technical field [0001] The invention relates to a device for early diagnosis and treatment effect inspection of cancer, which is characterized in that the device (instrument) organically integrates a specially selected fluorescence spectrometer, a polarizing device group with sharpening processing units with different characteristics, refrigerated centrifugal Machine, a specific diluter and a computer with a variety of data processing software, etc., constitute an automated complete detection device (instrument). This integrated test device has not been seen at home and abroad. It can be used to measure the fluorescence spectrum of cancer patient serum, from which the intensity ratio I of the main peak at 515nm and the characteristic peak at 624nm can be given 515nm / I 624nm , the normalized half-peak width value of the main peak, the parallel-perpendicular, perpendicular-parallel, parallel-parallel, and perpendicular-vertical normalized half-peak width values ​​of the polar...

AI Technical Summary

Problems solved by technology

Therefore, the principle of using the fluorescence spectrum of blood to diagnose cancer early and the corresponding device have not been obtained so far.

At the same time, the method of introducing laser light directly into the body to generate fluorescence spectrum for early diagnosis of cancer is not only unclear, but also the characteristics and changing rules of this fluorescence spectrum are still unclear. Therefore, this method is currently unfeasible.

Images